STOCK TITAN

[144] Xencor Inc SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

XNCR Form 144 discloses a proposed sale of 4,118 common shares tied to restricted stock vesting, listed as an issuer compensation transfer effective 03/04/2026. The filing also reports prior sales by John Desjarlais: 73,367 shares for $11,534,819.99 on 12/19/2025 and 2,663 shares for $31,676.65 on 03/03/2026.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Xencor

NASDAQ:XNCR

XNCR Rankings

XNCR Latest News

XNCR Latest SEC Filings

XNCR Stock Data

818.46M
70.35M
Biotechnology
Pharmaceutical Preparations
Link
United States
PASADENA